Pharmesis International Ltd.

SGX:BFK Stock Report

Market Cap: S$19.0m

Pharmesis International Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Pharmesis International.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth17.0%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Is Pharmesis International (SGX:BFK) Using Too Much Debt?

Oct 10
Is Pharmesis International (SGX:BFK) Using Too Much Debt?

Would Pharmesis International (SGX:BFK) Be Better Off With Less Debt?

Dec 09
Would Pharmesis International (SGX:BFK) Be Better Off With Less Debt?

Health Check: How Prudently Does Pharmesis International (SGX:BFK) Use Debt?

Jun 08
Health Check: How Prudently Does Pharmesis International (SGX:BFK) Use Debt?

A Look At The Intrinsic Value Of Pharmesis International Ltd. (SGX:BFK)

Feb 23
A Look At The Intrinsic Value Of Pharmesis International Ltd. (SGX:BFK)

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Pharmesis International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SGX:BFK - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202442-7-7-7N/A
3/31/202444-6-10-9N/A
12/31/202346-5-12-12N/A
9/30/202352-3-9-8N/A
6/30/202359-2-5-5N/A
3/31/202355-311N/A
12/31/202250-467N/A
9/30/202248-333N/A
6/30/202246-2-10N/A
3/31/2022500-10N/A
12/31/2021531-11N/A
9/30/202153-101N/A
6/30/202153-202N/A
3/31/202150-412N/A
12/31/202047-612N/A
9/30/202045-1306N/A
6/30/202038-16-25N/A
3/31/202039-17-15N/A
12/31/201937-18-42N/A
9/30/201942-7-5-2N/A
6/30/201948-4-6-3N/A
3/31/201957-2-4-1N/A
12/31/2018641-14N/A
9/30/201867-2-41N/A
6/30/201871-126N/A
3/31/201870-2N/A0N/A
12/31/201770-2N/A3N/A
9/30/201772-4N/A-29N/A
6/30/201771-4N/A-32N/A
3/31/201770-4N/A-25N/A
12/31/201669-5N/A-31N/A
9/30/2016650N/A6N/A
6/30/2016640N/A12N/A
3/31/2016631N/A7N/A
12/31/2015622N/A11N/A
9/30/201561-2N/A11N/A
6/30/201563-3N/A3N/A
3/31/201561-3N/A9N/A
12/31/201461-4N/A9N/A
9/30/2014631N/A3N/A
6/30/2014622N/A4N/A
3/31/2014631N/A1N/A
12/31/2013650N/A2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if BFK's forecast earnings growth is above the savings rate (2.2%).

Earnings vs Market: Insufficient data to determine if BFK's earnings are forecast to grow faster than the SG market

High Growth Earnings: Insufficient data to determine if BFK's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if BFK's revenue is forecast to grow faster than the SG market.

High Growth Revenue: Insufficient data to determine if BFK's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if BFK's Return on Equity is forecast to be high in 3 years time


Discover growth companies